Skip to main content
TERUMO CORPORATION logo

TERUMO CORPORATION — Investor Relations & Filings

Ticker · 4543 ISIN · JP3546800008 LEI · 353800JX1R4582QVK932 SGX Manufacturing
Open in API
Filings indexed 89 across all filing types
Latest filing 2024-11-11 Report Publication Anno…
Country JP Japan
Listing SGX 4543

About TERUMO CORPORATION

https://www.terumo.co.jp/

Terumo Corporation is a global medical technology company that develops, manufactures, and markets a broad portfolio of medical devices, equipment, and solutions. Its core business activities are centered on several key areas: Cardiac and Vascular, Blood and Cell Technologies, and Hospital and Pharmaceutical Solutions. The Cardiac and Vascular business provides products for interventional procedures, neurovascular therapies, and cardiovascular surgery. The Blood and Cell Technologies division offers solutions for blood transfusion, apheresis, and cell therapy processing. The company also supplies general hospital products, including infusion systems and medical disposables, alongside life care products for consumers and specialized pharmaceutical solutions that integrate drugs with delivery devices.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a confirmation document ("確認書") submitted to the Kanto Local Finance Bureau Director ("関東財務局長") on November 11, 2024. Section 1 explicitly states that the CEO confirms the appropriateness of the contents of the "Semi-Annual Report" ("半期報告書") for the period from April 1, 2024, to September 30, 2024. A Semi-Annual Report corresponds to a comprehensive financial report for a period shorter than a year, which aligns with the definition of an Interim / Quarterly Report (Code: IR). Since this document is the CEO's confirmation *about* the report, and not the report itself, it is a regulatory filing related to the submission of that report. However, given the specific content confirming the accuracy of a semi-annual report, it is closely tied to the IR filing. In many contexts, such confirmation documents are classified under the general regulatory filing category if a specific code for 'Confirmation of Filing Accuracy' does not exist. Since the core subject is the Semi-Annual Report (IR), and this is a formal regulatory submission, it fits best under the general Regulatory Filings (RNS) as a specific confirmation document, or potentially as a specialized part of the IR process. Given the options, RNS is the most appropriate fallback for a specific regulatory confirmation document that isn't the primary financial statement itself, although it directly relates to the IR period.
2024-11-11 Japanese
半期報告書－第110期(2024/04/01－2025/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Terumo Corporation with the Kanto Local Finance Bureau on November 11, 2024. It covers the interim accounting period from April 1, 2024, to September 30, 2024. This is a formal, comprehensive financial report containing financial statements, management analysis, and corporate information, which corresponds to the definition of an Interim/Quarterly Report (IR). H1 2025
2024-11-11 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and references the Financial Instruments and Exchange Act (金融商品取引法). It details the acquisition of treasury stock (自己株式) during a specific reporting period (September 17, 2024, to September 30, 2024), including the number of shares acquired and the total amount spent. This specific reporting requirement for share repurchases falls under the category of reporting transactions in a company's own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2024-10-11 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is titled "訂正発行登録書" (Correction Registration Statement) and is submitted to the Kanto Local Finance Bureau Director. It explicitly mentions the original filing date (March 15, 2024) and the reason for correction: to reference an amendment to a previous Extraordinary Report (臨時報告書). The security type being registered is "社債" (Corporate Bonds). This structure strongly indicates a filing related to the registration of securities issuance, specifically a correction to that registration. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate category for filings related to bond issuance and capital structure changes, even when it is a correction document. It is not a general regulatory announcement (RNS) because it pertains to a specific financing instrument registration.
2024-09-12 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 100% confidence The document is a Japanese regulatory filing, indicated by the header structure and the reference to '臨時報告書' (Extraordinary Report/Timely Disclosure Report) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) on August 29, 2024. The content explicitly details the '売出し' (Offering/Sale) of the company's common stock, including the number of shares (73,211,900), offering price, underwriters, and sale method. This type of filing, which reports a significant capital/financing event like a large share offering, aligns best with the 'Capital/Financing Update' category (CAP). Although it is a formal regulatory filing, the specific nature of the transaction (share offering) makes CAP more precise than the general 'RNS' fallback. The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2024-09-12 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is titled '訂正発行登録書' (Correction Registration Statement) and is submitted to the Kanto Local Finance Bureau ('関東財務局長'). It specifically deals with '社債' (Corporate Bonds) and references an '発行登録書' (Shelf Registration Statement) previously filed. The purpose of this filing is to correct a previous filing (an amendment to a Current Report filed on August 29, 2024) and designate the original Shelf Registration Statement as a reference document. This structure—a correction filing related to debt securities registration—fits best under the 'Capital/Financing Update' category, as it directly relates to the company's financing activities and capital structure documentation, even though it is a correction filing. The closest specific code is CAP (Capital/Financing Update). It is not a standard 10-K, AR, or ER.
2024-09-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.